Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Novo Nordisk reported earnings, posting some chunky year-over-year growth and far outperforming its only real rival at the moment, Eli Lilly.
Nintendo revealed on Tuesday that it had suffered a 69% drop in its profits year-over-year for the most recent financial quarter.
Ferrari reported improved sales and earnings in the third quarter, extending its streak of outperforming other luxury auto companies.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
FERC kiboshed a bid to increase the amount of power that a nuclear plant in Pennsylvania is allowed to supply to one of Amazon’s data centers.
Autonomy has been a part of Tesla’s vision for a long time, with its recent focus on robotaxis doubling down on the market.
This weekend, TGI Fridays filed for Chapter 11 bankruptcy, making it the latest in its class to raise the white flag.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
Music streaming services that offer more or less all the recorded music in history. So how is the industry supposed to grow?
Peloton announced that it has appointed Peter Stern as CEO and president to pedal the company out of its prolonged post-pandemic slump.
Comcast’s president floated the idea that the telecom giant and NBCUniversal parent company might spin off its portfolio of cable channels.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.